866-997-4948(US-Canada Toll Free)

Global Market Study on Human Papillomavirus (HPV) Testing: North America Projected to Remain the Dominant Regional Market Through 2025

Published By :

Persistence Market Research

Published Date : Jul 2017

Category :

Healthcare

No. of Pages : 242 Pages

Report Introduction

The report ‘Human Papillomavirus (HPV) Testing Market: Global Industry Analysis 2012 – 2016 and Forecast 2017 – 2025’ is a comprehensive compilation on the human papillomavirus (HPV) testing market and contains exclusive information regarding the market analysis, growth and forecasts for the period from 2017 till 2025. HPVs is a group of viruses, and each virus is given a type called HPV Type. HPV viruses are termed as papilloma viruses owing to their tendencies to cause warts or papilloma. A few HPVs are cancer causing viruses. HPVs can be grouped into low-risk genital HPV types and high-risk genital HPV types. HPVs which are non-cancerous and cause warts are termed as low-risk genital HPVs whereas cancer causing HPVs are termed as high-risk genital HPVs. There are over 150 types of HPVs, amongst which 14 types of HPVs are highly involved in cervical cancers. Human Papillomavirus (HPV) testing detects the presence of HPVs in women’s cervix. A positive HPV test indicates that the person should be monitored to identify any possibilities of developing cancers from abnormal cells. The limitation of HPV based screening for cervical cancer is that currently HPV tests are not approved for men.

Report Inclusions

This report is divided into four distinct parts. The first part consists of the introduction to the human papillomavirus (HPV) testing market. The next section consists of the regional human papillomavirus (HPV) testing market analysis and forecast. The report also contains the competitive landscape of the global human papillomavirus (HPV) testing market and gives the list of the important players operating in this lucrative market. Towards the end, the global human papillomavirus (HPV) testing market analysis 2012–2016 and forecast 2017–2025 by region, by product, by application and by end user is stated.  

In the introduction section, the pertinent market numbers of the global human papillomavirus (HPV) testing market are given along with the CAGR for the forecast period 2017-2025. The introduction also contains an executive summary of this detailed report through which the report audiences can have a cursory glance at this vast market. A list of approved products for HPV testing is also highlighted in the introduction. The macroeconomic factors affecting the human papillomavirus (HPV) testing market and their weightage factor is also given in the introduction. 

The next section of the report contains the regional human papillomavirus (HPV) testing market analysis and forecast as well as important market metrics such as BPS analysis, year-on-year growth rates, absolute dollar opportunity and market attractiveness analysis of the human papillomavirus (HPV) testing market. In this section, the regional drivers, restraints and trends are also indicated to help report audiences identify factors aiding the growth of this market as well as factors hampering the growth of this market across the various assessed regions. Besides the drivers and restraints, the trends that are applicable in the global human papillomavirus (HPV) testing market are also discussed region-wise in this section of the report. In addition, key regulations pertaining to the particular region which is being discussed is also presented here. Along with this, PESTLE analysis and Porter’s Five Force analysis is also detailed in this section of the report. Both the PESTLE analysis and Porter’s Five Force analysis are presented in a regional context so that all factors operating in that particular region are covered thoroughly. 

The last part of the report contains the competitive landscape of the human papillomavirus (HPV) testing market. This part constitutes information on the key market players. This competition landscape gives a dashboard view of the key companies operating in the global human papillomavirus (HPV) testing market along with their important information and broad strategy adopted to stay as leaders in the global human papillomavirus (HPV) testing market. Each of the leading companies is also profiled individually and important information about the company such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis is presented. 

Why should you invest in this report?

If you are ready to enter the global human papillomavirus (HPV) testing market, then this report is a comprehensive guide and will give you useful insights into this vast and lucrative market. All the aspects of HPV testing are covered in this report and information is also given on the various important regions of the world where this market is likely to boom in the near future and during the forecast period of 2017-2025 to help you plan your strategies accordingly. Besides, through this report, you can gain a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, then this report will help you gauge the strategies your competitors have adopted to stay as leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

A tested and proven research methodology for accurate estimation of market performance

Overall market size has been analyzed through historical data, primary responses, and public domain data. Revenue of companies in the human papillomavirus (HPV) testing market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to forecast the market size over the eight year period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated using the triangulation method and is extensively scrutinized using advanced tools to garner quantitative and qualitative insights into the global human papillomavirus (HPV) testing market. 

Market Taxonomy

Product

  • DNA-based Test
  • RNA-based Test

End User

  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Research Institutes

Applications

  • Molecular Diagnostics
  • Research Use

Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. PMR Analysis and Recommendations
1.4. Wheel of Fortune

2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
2.3. Regulatory Scenario

3. Human Papillomavirus (HPV) Testing Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis

4. North America Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
4.1. Introduction
4.2. Key Regulations
4.3. Regional Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Trends
4.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
4.4.1. U.S.
4.4.2. Canada
4.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
4.5.1. U.S.
4.5.2. Canada
4.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
4.6.1. DNA-based Test
4.6.2. RNA-based Test
4.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
4.7.1. DNA-based Test
4.7.2. RNA-based Test
4.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
4.8.1. Hospitals
4.8.2. Clinics
4.8.3. Diagnostic Centers
4.8.4. Research Institutes
4.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
4.9.1. Hospitals
4.9.2. Clinics
4.9.3. Diagnostic Centers
4.9.4. Research Institutes
4.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
4.10.1. Molecular Diagnostics
4.10.2. Research Use
4.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
4.11.1. Molecular Diagnostics
4.11.2. Research Use
4.12. Drivers and Restraints: Impact Analysis
4.13. Market Attractiveness Analysis
4.13.1. By Country
4.13.2. By Product
4.13.3. By End User
4.13.4. By Applications
4.14. Key Representative Market Participants
4.15. Market Presence (Intensity Map)

5. Latin America Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
5.1. Introduction
5.2. Key Regulations
5.3. Regional Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Trends
5.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
5.4.1. Brazil
5.4.2. Mexico
5.4.3. Argentina
5.4.4. Rest of Latin America
5.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
5.5.1. Brazil
5.5.2. Mexico
5.5.3. Argentina
5.5.4. Rest of Latin America
5.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
5.6.1. DNA-based Test
5.6.2. RNA-based Test
5.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
5.7.1. DNA-based Test
5.7.2. RNA-based Test
5.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
5.8.1. Hospitals
5.8.2. Clinics
5.8.3. Diagnostic Centers
5.8.4. Research Institutes
5.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
5.9.1. Hospitals
5.9.2. Clinics
5.9.3. Diagnostic Centers
5.9.4. Research Institutes
5.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
5.10.1. Molecular Diagnostics
5.10.2. Research Use
5.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
5.11.1. Molecular Diagnostics
5.11.2. Research Use
5.12. Drivers and Restraints: Impact Analysis
5.13. Market Attractiveness Analysis
5.13.1. By Country
5.13.2. By Product
5.13.3. By End User
5.13.4. By Applications
5.14. Key Representative Market Participants
5.15. Market Presence (Intensity Map)

6. Europe Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
6.1. Introduction
6.2. Key Regulations
6.3. Regional Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Trends
6.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
6.4.1. Germany
6.4.2. France
6.4.3. Russia
6.4.4. Italy
6.4.5. Spain
6.4.6. U.K.
6.4.7. Netherlands
6.4.8. Rest of Europe
6.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
6.5.1. Germany
6.5.2. France
6.5.3. Russia
6.5.4. Italy
6.5.5. Spain
6.5.6. U.K.
6.5.7. Netherlands
6.5.8. Rest of Europe
6.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
6.6.1. DNA-based Test
6.6.2. RNA-based Test
6.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
6.7.1. DNA-based Test
6.7.2. RNA-based Test
6.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
6.8.1. Hospitals
6.8.2. Clinics
6.8.3. Diagnostic Centers
6.8.4. Research Institutes
6.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
6.9.1. Hospitals
6.9.2. Clinics
6.9.3. Diagnostic Centers
6.9.4. Research Institutes
6.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
6.10.1. Molecular Diagnostics
6.10.2. Research Use
6.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
6.11.1. Molecular Diagnostics
6.11.2. Research Use
6.12. Drivers and Restraints: Impact Analysis
6.13. Market Attractiveness Analysis
6.13.1. By Country
6.13.2. By Product
6.13.3. By End User
6.13.4. By Applications
6.14. Key Representative Market Participants
6.15. Market Presence (Intensity Map)

7. Asia Pacific Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
7.1. Introduction
7.2. Key Regulations
7.3. Regional Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Trends
7.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
7.4.1. China
7.4.2. India
7.4.3. Japan
7.4.4. Australia and New Zealand
7.4.5. Rest of Asia Pacific
7.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
7.5.1. China
7.5.2. India
7.5.3. Japan
7.5.4. Australia and New Zealand
7.5.5. Rest of Asia Pacific
7.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
7.6.1. DNA-based Test
7.6.2. RNA-based Test
7.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
7.7.1. DNA-based Test
7.7.2. RNA-based Test
7.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
7.8.1. Hospitals
7.8.2. Clinics
7.8.3. Diagnostic Centers
7.8.4. Research Institutes
7.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
7.9.1. Hospitals
7.9.2. Clinics
7.9.3. Diagnostic Centers
7.9.4. Research Institutes
7.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
7.10.1. Molecular Diagnostics
7.10.2. Research Use
7.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
7.11.1. Molecular Diagnostics
7.11.2. Research Use
7.12. Drivers and Restraints: Impact Analysis
7.13. Market Attractiveness Analysis
7.13.1. By Country
7.13.2. By Product
7.13.3. By End User
7.13.4. By Applications
7.14. Key Representative Market Participants
7.15. Market Presence (Intensity Map)

8. Middle East & Africa Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
8.1. Introduction
8.2. Key Regulations
8.3. Regional Market Dynamics
8.3.1. Drivers
8.3.2. Restraints
8.3.3. Trends
8.4. Historical Market Size (US$ Mn) Trend Analysis By Country, 2012–2016
8.4.1. GCC Countries
8.4.2. South Africa
8.4.3. Turkey
8.4.4. Rest of MEA
8.5. Market Size (US$ Mn) Forecast By Country, 2017–2025
8.5.1. GCC Countries
8.5.2. South Africa
8.5.3. Turkey
8.5.4. Rest of MEA
8.6. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
8.6.1. DNA-based Test
8.6.2. RNA-based Test
8.7. Market Size (US$ Mn) Forecast By Product, 2017–2025
8.7.1. DNA-based Test
8.7.2. RNA-based Test
8.8. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
8.8.1. Hospitals
8.8.2. Clinics
8.8.3. Diagnostic Centers
8.8.4. Research Institutes
8.9. Market Size (US$ Mn) Forecast By End User, 2017–2025
8.9.1. Hospitals
8.9.2. Clinics
8.9.3. Diagnostic Centers
8.9.4. Research Institutes
8.10. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
8.10.1. Molecular Diagnostics
8.10.2. Research Use
8.11. Market Size (US$ Mn) Forecast By Applications, 2017–2025
8.11.1. Molecular Diagnostics
8.11.2. Research Use
8.12. Drivers and Restraints: Impact Analysis
8.13. Market Attractiveness Analysis
8.13.1. By Country
8.13.2. By Product
8.13.3. By End User
8.13.4. By Applications
8.14. Key Representative Market Participants
8.15. Market Presence (Intensity Map)

9. Forecast Factors: Relevance and Impact

10. Forecast Assumptions

11. Competition Landscape
11.1. Competition Dashboard
11.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)
11.2.1. F. Hoffmann-La Roche Ltd.
11.2.2. Agilent Technologies, Inc.
11.2.3. Becton, Dickinson and Company
11.2.4. Qiagen N.V.
11.2.5. Thermo Fisher Scientific Inc.
11.2.6. Abbott Laboratories
11.2.7. Hologic Inc.
11.2.8. Cepheid Inc.
11.2.9. Seegene Inc.
11.2.10. Takara Bio Inc.
11.2.11. DaAn Gene Co., Ltd. of Sun Yat-Sen University
11.2.12. Promega Corporation
11.2.13. Greiner Bio-One International GmbH (Greiner Holding AG)
11.2.14. Enzo Biochem Inc.
11.2.15. Norgen Biotek Corp.
11.2.16. DiagCor Bioscience Inc Ltd
11.2.17. Hybribio Limited
11.2.18. Zytovision GmbH
11.2.19. Arbor Vita Corporation
11.2.20. Medical & Biological Laboratories Co., Ltd
11.2.21. Fujirebio Diagnostics, Inc.

12. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Region
12.1. Introduction/Key Findings
12.2. Historical Market Size (US$ Mn) Trend Analysis By Region, 2012–2016
12.2.1. North America
12.2.2. Latin America
12.2.3. Europe
12.2.4. Asia Pacific
12.2.5. Middle East & Africa
12.3. Market Size (US$ Mn) Forecast By Region, 2017–2025
12.3.1. North America
12.3.2. Latin America
12.3.3. Europe
12.3.4. Asia Pacific
12.3.5. Middle East & Africa
12.4. Market Attractiveness Analysis By Region

13. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Product
13.1. Introduction/Key Findings
13.2. Historical Market Size (US$ Mn) Trend Analysis By Product, 2012–2016
13.2.1. DNA-based Test
13.2.2. RNA-based Test
13.3. Market Size (US$ Mn) and Forecast By Product, 2017–2025
13.3.1. DNA-based Test
13.3.2. RNA-based Test
13.4. Market Attractiveness Analysis By Product

14. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025, By End User
14.1. Introduction/Key Findings
14.2. Historical Market Size (US$ Mn) Trend Analysis By End User, 2012–2016
14.2.1. Hospitals
14.2.2. Clinics
14.2.3. Diagnostic Centers
14.2.4. Research Institutes
14.3. Market Size (US$ Mn) Forecast By End User, 2017–2025
14.3.1. Hospitals
14.3.2. Clinics
14.3.3. Diagnostic Centers
14.3.4. Research Institutes
14.4. Market Attractiveness Analysis By End User

15. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025, By Applications
15.1. Introduction/Key Findings
15.2. Historical Market Size (US$ Mn) Trend Analysis By Applications, 2012–2016
15.2.1. Molecular Diagnostics
15.2.2. Research Use
15.3. Market Size (US$ Mn) Forecast By Applications, 2017–2025
15.3.1. Molecular Diagnostics
15.3.2. Research Use
15.4. Market Attractiveness Analysis By Applications

16. Global Human Papillomavirus (HPV) Testing Market Analysis 2012–2016 and Forecast 2017–2025
16.1. Market Size and Y-o-Y Growth
16.2. Absolute $ Opportunity

List of Table

Table 1: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 2: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Product Type
Table 3: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 4: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Applications
Table 5: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 6: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 & Forecast 2017-2025, By Product Type
Table 7: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 8: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 9: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 10: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 11: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 12: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Applications
Table 13: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 14: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product Type
Table 15: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 16: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Applications
Table 17: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Country
Table 18: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Product
Table 19: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By End User
Table 20: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) Analysis 2012-2016 and Forecast 2017-2025, By Applications
Table 21: Global Human Papillomavirus (HPV) Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Region, 
Table 22: Global Human Papillomavirus (HPV) Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By Product, 
Table 23: Global Human Papillomavirus (HPV) Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By End User, 
Table 24: Global Human Papillomavirus (HPV) Testing Market Size (US$ Mn) 2012–2016 and Forecast 2017-2025 By End User, 

List of Chart

Figure 1: North America HPV Testing Market Value Share By Product 
Figure 2: North America HPV Testing Market Value Share By End User 
Figure 3: North America HPV Testing Market Value Share By Applications 
Figure 4: North America HPV Testing Market Value Share By Country
Figure 5: North America Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 6: North America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 7: North America Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025 
Figure 8: North America Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 9: U.S. Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 10: Canada Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 11: North America HPV Testing Market Attractiveness Analysis, By Product
Figure 12: North America HPV Testing Market Attractiveness Analysis, By End User
Figure 13: North America HPV Testing Market Attractiveness Analysis, By Application
Figure 14: North America HPV Testing Market Attractiveness Analysis, By Region
Figure 15: Latin America HPV Testing Market Value Share By Product  
Figure 16: Latin America HPV Testing Market Value Share By End User  
Figure 17: Latin America HPV Testing Market Value Share By Applications  
Figure 18: Latin America HPV Testing Market Value Share By Country  
Figure 19: Latin America Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 20: Latin America Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 21: Latin America Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025 
Figure 22: Latin America Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 23: Brazil Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 24: Mexico Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 25: Argentina Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 26: Rest of Latin America Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 27: Latin America HPV Testing Market Attractiveness Analysis, By Product
Figure 28: Latin America HPV Testing Market Attractiveness Analysis, By End User
Figure 29: Latin America HPV Testing Market Attractiveness Analysis, By Application
Figure 30: Latin America HPV Testing Market Attractiveness Analysis, By Region
Figure 31: Europe HPV Testing Market Value Share By Product  
Figure 32: Europe HPV Testing Market Value Share By End User  
Figure 33: Europe HPV Testing Market Value Share By Applications  
Figure 34: Europe HPV Testing Market Value Share By Country  
Figure 35: Europe Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 36: Europe Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 37: Europe Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025 
Figure 38: Europe Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 39: Germany Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 40: France Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 41: Russia Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 42: Italy Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 43: Spain Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 44: U.K. Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 45: Netherlands Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 46: Rest of Europe Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 47: Europe HPV Testing Market Attractiveness Analysis, By Product
Figure 48: Europe HPV Testing Market Attractiveness Analysis, By End User
Figure 49: Europe HPV Testing Market Attractiveness Analysis, By Application
Figure 50: Europe HPV Testing Market Attractiveness Analysis, By Region
Figure 51: Asia Pacific HPV Testing Market Value Share By Product  
Figure 52: Asia Pacific HPV Testing Market Value Share By End User  
Figure 53: Asia Pacific HPV Testing Market Value Share By Applications  
Figure 54: Asia Pacific HPV Testing Market Value Share By Country  
Figure 55: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 56: Asia-Pacific Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 57: Asia-Pacific Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025 
Figure 58: Asia-Pacific Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 59: China Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 60: India Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 61: Japan Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 62: Australia & New Zealand HPV Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 63: Rest of Asia Pacific HPV Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 64: Asia Pacific HPV Testing Market Attractiveness Analysis, By Product
Figure 65: Asia Pacific HPV Testing Market Attractiveness Analysis, By End User
Figure 66: Asia Pacific HPV Testing Market Attractiveness Analysis, By Application
Figure 67: Asia Pacific HPV Testing Market Attractiveness Analysis, By Region
Figure 68: Middle East & Africa HPV Testing Market Value Share By Product  
Figure 69: Middle East & Africa HPV Testing Market Value Share By End User  
Figure 70: Middle East & Africa HPV Testing Market Value Share By Applications  
Figure 71: Middle East & Africa HPV Testing Market Value Share By Country  
Figure 72: MEA Human Papillomavirus (HPV) Testing Market Size Analysis, 2012–2016
Figure 73: MEA Human Papillomavirus (HPV) Testing Market Size (US$ Mn) & Y-o-Y Growth (%), 2017–2025
Figure 74: MEA Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025
Figure 75: MEA Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 76: GCC Countries Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 77: South Africa Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 78: Turkey Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 79: Rest of MEA Human Papillomavirus (HPV) Testing Market Value & Absolute $ Opportunity, by Country, 2017–2025
Figure 80: MEA HPV Testing Market Attractiveness Analysis, By Product
Figure 81: MEA HPV Testing Market Attractiveness Analysis, By End User
Figure 82: MEA HPV Testing Market Attractiveness Analysis, By Application
Figure 83: MEA HPV Testing Market Attractiveness Analysis, By Region
Figure 84: Global Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Country, 2017 & 2025
Figure 85: Global Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Country, 2016–2025
Figure 86: Global Human Papillomavirus (HPV) Testing Market Attractiveness Analysis By Region, 2017–2025
Figure 87: Global Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Product, 2017 & 2025
Figure 88: Global Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Product, 2016–2025
Figure 89: Global Human Papillomavirus (HPV) Testing Market Attractiveness Analysis By Product Type, 2017–2025
Figure 90: Global Human Papillomavirus (HPV) Testing Market Share Analysis (%) By End User, 2017 & 2025
Figure 91: Global Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By End User, 2016–2025
Figure 92: Global Human Papillomavirus (HPV) Testing Market Attractiveness Analysis By End User, 2017–2025
Figure 93: Global Human Papillomavirus (HPV) Testing Market Share Analysis (%) By Applications, 2017 & 2025
Figure 94: Global Human Papillomavirus (HPV) Testing Market Y-o-Y Growth (%) By Applications, 2016–2025
Figure 95: Global Human Papillomavirus (HPV) Testing Market Attractiveness Analysis By End User, 2017–2025
Figure 96: Global Human Papillomavirus (HPV) Testing Market Value Analysis and Forecast, 2016–2025 (US$ Mn)
Figure 97: Global Human Papillomavirus (HPV) Testing Market Absolute $ Opportunity (US$ Mn), 2012–2016
Figure 98: Global Human Papillomavirus (HPV) Testing Market Absolute $ Opportunity (US$ Mn), 2016–2025

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *